Related Experiment Videos
The AVE Micro Coronary Stent as a Bailout Device
1Department of Cardiology, Royal Brompton Hospital, London, SW3 6NP, United Kingdom.
The Journal of Invasive Cardiology
|June 1, 1997
Summary
The AVE Micro coronary stent effectively manages abrupt vessel closure after percutaneous transluminal coronary angioplasty (PTCA). This bailout strategy shows a high success rate and acceptable complication profile for coronary interventions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Vessel closure after percutaneous transluminal coronary angioplasty (PTCA) is a significant cause of patient morbidity and mortality.
- Effective management strategies are crucial for improving outcomes in patients experiencing abrupt or threatened abrupt vessel closure.
Purpose of the Study:
- To evaluate the safety and efficacy of the AVE Micro coronary stent in bailout situations following PTCA.
- To assess the outcomes of patients treated with the AVE Micro stent for abrupt or threatened abrupt vessel closure.
Main Methods:
- A retrospective analysis of 86 consecutive patients who received the AVE Micro coronary stent for abrupt or threatened abrupt vessel closure post-PTCA between January 1995 and January 1996.
- Data collected included patient demographics, clinical presentation, procedural details, and short-term clinical outcomes.
Main Results:
- A total of 109 AVE Micro stents were implanted in 86 patients.
- The procedural success rate was high, with only one procedural failure.
- Key complications included subacute stent thrombosis (7%), major vascular complications (4%), and a 30-day event-free survival rate of 72%.
Conclusions:
- The AVE Micro coronary stent is an effective device for managing abrupt and threatened abrupt vessel closure following PTCA.
- Its use in bailout scenarios demonstrates a high procedural success rate and a relatively low complication rate, supporting its role in interventional cardiology.